Skip to main content
. 2022 Jun 1;2022:1617229. doi: 10.1155/2022/1617229

Figure 5.

Figure 5

HUC-MSCs regulate inflammatory cytokine production in colitis and colitis-related colon cancer. (a–c) HUC-MSC treatment reduced TNF-α and IL-6 while increased TGF-β1 in the serum of AOM/DSS-treated mice. (d, e) HUC-MSC treatment reduced proinflammatory cytokines produced by macrophages in serum caused by DSS. (f, g) HUC-MSC treatment reduced IFN-γ and IL-4 in serum of colitis mice. (h, i) HUC-MSC treatment reduced IL-17 while increased TGF-β1 in serum caused by DSS. Error bars: mean ± SD. p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.005.